Table 2.
Survey Respondent Characteristics Based on Overall Satisfaction
| Demographic characteristic | Dissatisfied | Neutral | Satisfied | p-value |
|---|---|---|---|---|
| All | 94 (21.9) | 69 (16.0) | 266 (61.9) | - |
| Year | 0.002a) | |||
| 2 | 1 (7.1) | 2 (14.3) | 11 (78.6) | |
| 3 | 76 (26.4) | 50 (17.4) | 162 (56.2) | |
| 4 | 17 (13.4) | 17 (13.4) | 93 (73.2) | |
| Race | 0.371a) | |||
| Asian/Pacific Islander | 23 (20.9) | 18 (16.4) | 69 (62.7) | |
| Black or African American | 12 (22.6) | 9 (17.0) | 32 (60.4) | |
| Hispanic or Latino | 4 (12.9) | 3 (9.7) | 24 (77.4) | |
| White | 43 (21.5) | 36 (18.0) | 121 (60.5) | |
| None of the above/mixed | 12 (34.3) | 3 (8.6) | 20 (57.1) | |
| Gender | 0.038a) | |||
| Female | 66 (27.8) | 29 (12.2) | 142 (59.9) | |
| Male | 28 (15.0) | 37 (19.8) | 122 (65.2) | |
| Non-binary/non-conforming | 0 | 3 (75.0) | 1 (25.0) | |
| Prefer not to respond | 0 | 0 | 1 (100.0) | |
| Self-perceived socioeconomic status | 0.993a) | |||
| Lower class | 5 (25.0) | 2 (10.0) | 13 (65.0) | |
| Lower middle class | 17 (25.4) | 7 (10.4) | 43 (64.2) | |
| Middle class | 27 (20.9) | 27 (20.9) | 75 (58.1) | |
| Upper middle class | 36 (20.8) | 31 (17.9) | 106 (61.3) | |
| Upper class | 9 (23.7) | 2 (5.3) | 27 (71.1) | |
| Region | 0.005a) | |||
| Midwest | 15 (24.6) | 12 (19.7) | 34 (55.7) | |
| Northeast | 14 (15.4) | 12 (13.2) | 65 (71.4) | |
| South | 43 (29.5) | 28 (19.2) | 75 (51.4) | |
| West | 22 (16.8) | 17 (13.0) | 92 (70.2) | |
| Categorized as | 0.238a) | |||
| Healthcare worker | 31 (20.4) | 15 (9.9) | 106 (69.7) | |
| Student | 63 (22.7) | 54 (19.5) | 160 (57.8) | |
| Vaccine status | 0.001a) | |||
| Vaccinated/will receive earlier than general population | 86 (20.7) | 67 (16.1) | 262 (63.1) | |
| Will receive same time as general population/unsure | 8 (57.1) | 2 (14.3) | 4 (28.6) | |
| Testing status | <0.001 | |||
| Both clinical and preclinical students tested | 21 (16.7) | 16 (12.7) | 89 (70.6) | |
| Clinical students tested; pre-clinical students not tested | 28 (11.8) | 50 (21.1) | 159 (67.1) | |
| Clinical students not tested; pre-clinical students tested | 25 (80.6) | 4 (12.9) | 2 (6.5) | |
| Both clinical and preclinical students not tested | 15 (41.7) | 14 (38.9) | 7 (19.4) | |
| Age (yr) | 26 (25–27) | 26 (25–27) | 26 (25–27) | 0.565b) |
| Medical school enrollment size | 746 (602–750) | 679 (598–750) | 624 (598–746) | 0.002b) |
Data are presented as number (%) or median (interquartile range). Satisfaction reported with the “testing status” variable is satisfaction with coronavirus disease 2019 testing.
a)
Derived using the Pearson chi-square test (neutral responses are excluded).
b)
Derived using the Wilcoxon rank-sum test (neutral responses as excluded).